IBOV 172,060.43 ▲ 0.42% IPC MEX 72,006.05 ▲ 0.16% MERVAL 2,848,945 — — USD/BRL5.58▲ 0.03% USD/MXN18.60▲ 0.02% USD/CLP982.08▼ 0.22% USD/COP3,279▼ 0.85% USD/PEN3.41▼ 0.02% USD/ARS1,544▼ 0.03% USD/UYU40.52▲ 3.32% USD/PYG6,174▲ 3.14% USD/BOB11.63▲ 1.12% USD/DOP60.48▲ 0.05% USD/CRC446.01▲ 1.79% USD/GTQ7.64▲ 3.16% USD/HNL26.90▲ 3.29% USD/NIO36.62▲ 2.73% USD/VES902.19▼ 0.13% USD/PAB1.00— 0.00% USD/BZD2.00— 0.00% USD/JMD157.49▲ 2.41% USD/TTD6.72▲ 2.22% EUR/BRL6.19▼ 0.61% BRENT 93.22 ▲ 0.50% WTI 86.94 ▲ 0.47% IRON ORE 161.91 — — COPPER 6.23 ▼ 0.73% GOLD 3,969 ▼ 0.78% SILVER 51.42 ▼ 0.90% SOY 1,226 ▼ 0.24% CORN 447.75 ▼ 0.06% WHEAT 599.50 — 0.00% COFFEE 265.45 ▼ 2.19% SUGAR 18.47 ▲ 2.10% ORANGE JUICE 146.60 ▼ 0.10% COTTON 82.35 ▲ 4.65% COCOA 5,061 ▲ 6.73% BEEF 218.98 ▼ 0.10% CATTLE 327.80 ▼ 0.77% LITHIUM 61.07 ▲ 1.82% PETR4 43.55 ▼ 3.11% VALE3 64.43 ▼ 0.57% ITUB4 41.72 ▲ 1.26% BBDC4 14.33 ▼ 1.44% ABEV3 15.85 ▲ 0.38% BBAS3 16.89 ▼ 1.23% B3SA3 14.80 ▲ 2.21% WEGE3 51.61 ▲ 1.30% PRIO3 61.47 ▲ 2.42% SUZB3 53.80 ▼ 1.21% RENT3 30.24 ▲ 1.51% AZZA3 15.37 ▲ 4.34% CSAN3 3.03 ▲ 13.06% RAIZ4 0.30 ▼ 98.60% PCAR3 2.54 ▼ 0.78% GMAT3 4.08 ▲ 7.09% PSSA3 45.98 ▼ 1.48% CVCB3 0.86 — 0.00% POSI3 3.32 ▲ 5.40% SLCE3 17.05 ▼ 0.23% NATU3 5.62 ▲ 1.26% BRKM5 2.92 — 0.00% RANI3 8.39 ▼ 0.71% CSNA3 4.52 ▲ 3.20% IBOV 172,060.43 ▲ 0.42% IPC MEX 72,006.05 ▲ 0.16% MERVAL 2,848,945 — — USD/BRL 5.58 ▲ 0.03% USD/MXN 18.61 ▲ 0.03% USD/CLP 982.08 ▼ 0.22% USD/COP 3,279 ▼ 0.85% USD/PEN 3.41 ▼ 0.02% USD/ARS 1,544 ▼ 0.11% USD/UYU 40.52 ▲ 3.70% USD/PYG 6,174 ▲ 3.14% USD/BOB 11.63 ▲ 1.12% USD/DOP 60.48 ▲ 0.05% USD/CRC 446.01 ▲ 1.79% USD/GTQ 7.64 ▲ 3.16% USD/HNL 26.90 ▲ 3.29% USD/NIO 36.62 ▲ 2.73% USD/VES 902.19 ▼ 0.13% USD/PAB 1.00 — 0.00% USD/BZD 2.00 — 0.00% USD/JMD 157.49 ▲ 2.41% USD/TTD 6.72 ▲ 2.22% EUR/BRL 6.19 ▼ 0.62% BRENT 93.22 ▲ 0.50% WTI 86.94 ▲ 0.47% IRON ORE 161.91 — — COPPER 6.23 ▼ 0.73% GOLD 3,969 ▼ 0.78% SILVER 51.42 ▼ 0.90% SOY 1,226 ▼ 0.24% CORN 447.75 ▼ 0.06% WHEAT 599.50 — 0.00% COFFEE 265.45 ▼ 2.19% SUGAR 18.47 ▲ 2.10% ORANGE JUICE 146.60 ▼ 0.10% COTTON 82.35 ▲ 4.65% COCOA 5,061 ▲ 6.73% BEEF 218.98 ▼ 0.10% CATTLE 327.80 ▼ 0.77% LITHIUM 61.07 ▲ 1.82% PETR4 43.55 ▼ 3.11% VALE3 64.43 ▼ 0.57% ITUB4 41.72 ▲ 1.26% BBDC4 14.33 ▼ 1.44% ABEV3 15.85 ▲ 0.38% BBAS3 16.89 ▼ 1.23% B3SA3 14.80 ▲ 2.21% WEGE3 51.61 ▲ 1.30% PRIO3 61.47 ▲ 2.42% SUZB3 53.80 ▼ 1.21% RENT3 30.24 ▲ 1.51% AZZA3 15.37 ▲ 4.34% CSAN3 3.03 ▲ 13.06% RAIZ4 0.30 ▼ 98.60% PCAR3 2.54 ▼ 0.78% GMAT3 4.08 ▲ 7.09% PSSA3 45.98 ▼ 1.48% CVCB3 0.86 — 0.00% POSI3 3.32 ▲ 5.40% SLCE3 17.05 ▼ 0.23% NATU3 5.62 ▲ 1.26% BRKM5 2.92 — 0.00% RANI3 8.39 ▼ 0.71% CSNA3 4.52 ▲ 3.20%
since 2009
Thursday, November 12, 2026

Covid-19 Brazil

Brazil may return to ‘normal life’ in October – UBS projection

By · · 3 min read

RIO DE JANEIRO, BRAZIL – If the expected vaccination rate against the coronavirus is maintained, Brazil may reach some kind of normality as early as October and extend the economic reopening. The projection is from analysts of Swiss bank UBS, in a report released to clients this week.

The estimate was made based on hospitalization data, expected vaccination for the coming months and the Brazilian age pyramid. According to the report, Brazil is expected to succeed in drastically reducing infections and severe cases of Covid-19 once the population aged 30 and older is immunized – which analysts expect may happen by October, based on the doses announced by the government.

1
Brazil may return to ‘normal life’ in October if the expected vaccination rate against the coronavirus is maintained.
RT
Ask Rio Times
This story and the bigger picture.
Open the full Ask Rio Times →

This immunized share would be lower than the 70% or more that experts assess as ideal to achieve some kind of “herd immunity.” In order for Brazil to reach 70% of its population immunized, it would also have to vaccinate adults aged 20 and older.

However, the UBS report estimates that it may be possible to reach what it calls “effective herd immunity” once Brazil has vaccinated a much smaller share of the population, only the group aged 30 and older, or 56% of the population.

Although it represents a little more than half of the population, the group aged 30 and older is accountable for over 95% of deaths, hospitalizations, and ICU admissions. It is also known that Covid-19 has been shown to be less lethal in adolescents and children.

“Thus, we name the achievement of immunity in this [30-year-old] group and in the population over 60 as ‘effective immunity’, allowing economic activity to normalize,” write economists Alexandre de Azara and Fabio Ramos, who sign the report.

So far, Brazil has vaccinated at least 17% of the population with one dose, and just over 8.5% with the second dose. This group comprises mainly seniors over 70 years of age and health professionals. There were 54 million doses administered, according to the media outlet consortium’s calculations based on the data provided by the states up to Monday, May 10.

What is required to get there?

About 16 million doses were administered monthly in Brazil in March and April. But to estimate that all adults aged 30 will be vaccinated by October, the UBS projects a significant increase in this number.

The projection is based mainly on AstraZeneca vaccine deliveries, currently produced by the Oswaldo Cruz Foundation, in addition to a portion sent by the Covax international consortium. The Coronavac immunizer accounts for almost 8 out of every 10 doses distributed in Brazil through late April.

According to UBS estimates, AstraZeneca’s vaccine should overtake the Coronavac and become the most widely administered in Brazil as early as May. The projections also include the arrival of doses bought by the federal government from Pfizer and Johnson & Johnson – the latter, only from October.

The calculation does not include future doses of the Russian Sputnik V vaccine or the Indian Covaxin, which still need to be approved by the Brazilian Health Regulatory Agency (ANVISA).

On the other hand, to meet the projection for the coming months, Brazil will have to overcome challenges in the purchase of the active pharmaceutical ingredient (API), currently coming from China. The delay in API delivery has slowed down the production of vaccines in Brazil.

On the other hand, the national production of API is likely to be delayed until the end of the year: Fiocruz has promised the first doses for August, but deferred the date to September and now experts are projecting the month of October for delivery to begin. The Butantan Institute is also building a plant to produce the raw material, which should only start operating next year.

Source: Exame

This article was produced by The Rio Times’ automated AI newsroom. Editorial responsibility: Matthias Camenzind, Publisher and Editor-in-Chief. The Rio Times also runs Ask Rio Times, which answers from 100,000+ of our own articles, the daily Latin America Power Map, and prediction-market odds on elections and markets.. How we use AI · Report an error

The Rio Times · Power Map
See who really holds power in Latin America
Click to open the Power Map →

Brazil runoff date: Sunday, October 25, poll closing times and when results start · Brazil runoff polls: Flávio 51%, Lula 49% · Kalshi and Polymarket odds

Rotate for Best Experience

This report is optimized for landscape viewing. Rotate your phone for the full experience.